Evolvable platform for programmable nanoparticle-based cancer therapies

We are a consortium of seven partners with the shared goal of creating an entirely new nanoparticle design platform for cancer treatment capable of autonomously evolving solutions to any tumour scenario.

Each partner in EVO-NANO has their own specific competencies and experience. The combination of our expertise and overlap of knowledge will make us achieve our objectives of create novel new cancer therapies.

Modelling

Build an evolutionary model to simulate all the main aspects of nanoparticles dynamics in the body and tumour environment.

Synthesis

Streamline synthesis of functionalised nanoparticles suggested by the evolutionary model

Validation

Validate efficacy of artificially evolved nanoparticle designs using in vitro micro-fluidics and in vivo pre-clinical tests

Recent News

Launch Meeting

Great kick-off meeting, kindly hosted by our partners in Val d'Hebron, Barcelona. Perfect opportunity to share our recent research, discuss the next steps for our cancer simulator and try some of Barcelona's famous tapas.

This project has received funding from the European Union's Horizon 2020 FET Open programme under grant agreement. No. 800983.